EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exozymes for Biomanufacturing: Toward Clarity and Precision in the Cell-Free Space

Adrian Brückner, Bastian Vögeli, John M. Billingsley, Paul H. Opgenorth, Erika Vielmas, Sylvia A. Sarnik, Michael Heltzen, Lasse Görlitz, James U. Bowie, Zachary Z. Sun, James Lalonde, Brian Brazeau und 2 weitere

GEN Biotechnology · 01.04.2025 · 4 (2) · 66-78

DOI: 10.1089/genbio.2025.0008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift GEN Biotechnology, online erschienen am 17.04.2025. Verfasst von Adrian Brückner und 13 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In biotechnology, the term ‘cell-free’ describes a wide range of established and emerging processes and technologies. However, broad application of the term ‘cell-free’ leads to confusion and ambiguity in the field, especially when applied to biomanufacturing. When engaging with investors, government agencies, and industry partners, we have found that the association of ‘cell-free’ with numerous technologies spanning diverse applications creates unnecessary confusion. As a result, we believe the lack of clarity complicates communication, impacts technology adoption, and creates challenges in securing funding and regulatory recognition. Specifically, in this opinion, we focus on terminology used to describe enzyme-driven biocatalytic approaches for manufacturing small molecules, often referred to as ‘cell-free biomanufacturing.’ This ‘cell-free’ approach harnesses biocatalytic pathways, in the absence of living cells, to synthesize small molecules used as pharmaceuticals, nutraceuticals, flavors, and fragrances, but also specific commodity chemicals and fuels. To clarify terminology, we introduce the new terms ‘exozymes’ and ‘exozyme systems’ as unambiguous descriptors for ‘cell-free biomanufacturing.’

Zitieren

APA

Brückner, A., Vögeli, B., Billingsley, J. M., Opgenorth, P. H., Vielmas, E., Sarnik, S. A., Heltzen, M., Görlitz, L., Bowie, J. U., Sun, Z. Z., Lalonde, J., Brazeau, B., Bomble, Y. J., & Korman, T. P. (2025). Exozymes for Biomanufacturing: Toward Clarity and Precision in the Cell-Free Space. GEN Biotechnology, 4(2), 66-78. https://doi.org/10.1089/genbio.2025.0008

Vancouver

Brückner A, Vögeli B, Billingsley JM, Opgenorth PH, Vielmas E, Sarnik SA, et al. Exozymes for Biomanufacturing: Toward Clarity and Precision in the Cell-Free Space. GEN Biotechnology. 2025;4(2):66-78. doi:10.1089/genbio.2025.0008

BibTeX
@article{Brckner2025,
  author = {Brückner, Adrian and Vögeli, Bastian and Billingsley, John M. and Opgenorth, Paul H. and Vielmas, Erika and Sarnik, Sylvia A. and Heltzen, Michael and Görlitz, Lasse and Bowie, James U. and Sun, Zachary Z. and Lalonde, James and Brazeau, Brian and Bomble, Yannick J. and Korman, Tyler P.},
  title = {Exozymes for Biomanufacturing: Toward Clarity and Precision in the Cell-Free Space},
  journal = {GEN Biotechnology},
  year = {2025},
  volume = {4},
  number = {2},
  pages = {66--78},
  doi = {10.1089/genbio.2025.0008}
}
Kostenlos starten →